ArticleScientific reports2025
Trends and disparities in mortality associated with peripheral artery disease and hyperlipidemia, 1999-2024.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Trends and racial-geographic disparities in mortality among US older adults with peripheral artery disease, 1999 to 2020.Proceedings (Baylor University. Medical Center) · 2026Article
- Temporal Trends and Future Projections of P ulmonary Embolism and Top Contributing Causes of death in the United States, 1968-2040: insights from the CDC WONDER database.Journal of thrombosis and thrombolysis · 2026Article
- Trends and disparities in deaths involving atherosclerotic cardiovascular disease and stroke-related conditions among U.S. adults, 1999-2025.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral artery disease (PAD) with hyperlipidemia adds significantly to the national burden of cardiovascular disease. However, population-level trends in mortality for these conditions are not well understood. We used nationally representative data to investigate long-term temporal patterns and disparities in PAD and hyperlipidemia related mortality in the United States. This descriptive analysis analyzed death records from the CDC WONDER database from 1999 to 2024. The age-adjusted mortality rates (AAMRs) per 100,000 people were calculated for each demographic and geographic strata. AAMRs were standardized to 2000 U.S. standard population. Temporal trends in AAMRs were analyzed using Joinpoint regression to estimate the average annual percent change (AAPC) with 95% confidence intervals (CIs) and p value. Between 1999 and 2024, a total of 148,416 PAD with hyperlipidemia-related deaths were recorded among U.S. adults ≥ 25 years. The national AAMR rose from 0.74 in 1999 to 3.92 in 2024, corresponding to an overall AAPC of 6.32. Both sexes experienced increasing mortality, though men had higher rates and faster growth compared with women. By race/ethnicity, AAMRs increased across all groups, with the steepest relative rise among Hispanic individuals, followed by Non-Hispanic (NH) Black, NH White, and NH Asian or Pacific Islander populations. Geographic disparities were observed, with state-level AAMRs ranging from 0.92 in Georgia to 5.06 in Vermont, and the highest regional mean AAMR in the West (2.93). Finally, rural areas consistently exhibited higher mean AAMRs than urban areas, with slightly steeper increase over time. AAMRs related to PAD and hyperlipidemia have increased more than fivefold, with disproportionately higher rates among men, Hispanic populations, residents of Western regions, and those in rural areas. These patterns suggest widening disparities in vascular health and underscore the need for strengthened preventive efforts, improved lipid management, and more equitable access to cardiovascular care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.